Lataa...
The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients
Glioblastoma Multiforme (GBM) is the most common type of brain tumor and it is uniformly fatal. The community standard of treatment for this disease is gross or subtotal resection of the tumor, followed by radiation and temozolomide. At recurrence bevacizumab can be added for increased progression f...
Tallennettuna:
| Julkaisussa: | Hum Vaccin Immunother |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514075/ https://ncbi.nlm.nih.gov/pubmed/25625931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.983002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|